"Laser" is an acronym for "light amplification by stimulated emission of radiation." A simple laser consists of a lasing medium enclosed between 2 mirrors, 1 of which is able to partially transmit light. When energy is applied to the lasing medium, more atoms of the medium attain an excited state. A photon that strikes an atom in the excited state will cause it to fall to a lower energy state and release a photon of the same wavelength, traveling in the same direction and in phase with the first photon-this process is stimulated emission. The coherence of laser light allows it to be focused into intense beams that can be used in many different applications. 14 Surgical lasers are typically applied for 3 functions: photocoagulation, to control bleeding and devitalize tissue; photovaporization, to incise and vaporize tissue; and photoactivation, to sensitize tissue or activate photoreactive drugs. The properties of both the laser and the affected tissue are important in determining laser-tissue interactions. Laser properties include wavelength (determined by the lasing medium, such as CO 2 ), power output (watts), beam density (spot size), and time of exposure. Together, these factors determine the energy density (W/ cm 2 × time) delivered to the tissue. Important properties inherent to the tissue itself include the absorption coefficient (absorbed light is rapidly converted to heat), the extinction length (the depth that light will penetrate), and the presence of light-absorbing chromophores such as water, hemoglobin, or melanin. 9 Taken together, laser and tissue factors determine the rate of tissue heating, the area of laser effect, and the type of lesion created. In this historical review the authors examine the important developments that have led to the availability of laser energy to neurosurgeons as a unique and sometimes invaluable tool. They review the physical science behind the function of lasers, as well as how and when various lasers based on different lasing mediums were discovered. They also follow the close association between advances in laser technology and their application in biomedicine, from early laboratory experiments to the first clinical experiences. Because opinions on the appropriate role of lasers in neurosurgery vary widely, the historical basis for some of these views is explored. Initial enthusiasm for a technology that appears to have innate advantages for safe resections has often given way to the strict limitations and demands of the neurosurgical operating theater. However, numerous creative solutions to improve laser delivery, power, safety, and ergonomics demonstrate the important role that technological advances in related scientific fields continue to offer neurosurgery. Benefiting from the most recent developments in materials science, current CO 2 laser delivery systems provide a useful addition to the neurosurgical armamentarium when applied in the correct circumstances and reflect the important historical advances that come about from the interplay between neurosurgery and technology. 
Discovery of Lasers and Early Animal Experiments
A timeline of important events in the use of lasers in neurosurgery appears in Fig. 1 . The first operational laser was described by Maiman 22 in 1960, while working at Hughes Research Laboratories; he used a ruby medium to produce a laser pulse with a 694-nm wavelength. The next reported laser, based in a helium-neon gas medium, was described in 1961 by Javan et al. 19 from Bell Laboratories in New Jersey. A number of other lasers using gas and solid-state media were developed: importantly, a molecular laser using CO 2 as the medium and producing a continuous wave laser at a wavelength of 10.6 µm, which was described in 1964 by Patel, 26 who was also working at Bell Laboratories. The early use of the laser for industrial or military applications was reflected in much of the research performed in nonacademic settings. Nonetheless, biomedical applications soon followed, and the first reported application of laser energy to the brain was detailed in 1965 in the experiments by Earle et al. 8 and Fine et al. 11 These authors applied a single high-energy pulse of a ruby laser to the intact craniums of mice and observed that the mice were instantly killed, their deaths resulting from rapid, explosive expansion of the intracranial contents and cerebral herniation. Other early investigators using pulsed lasers similarly found them to be destructive to neural tissue; however, death from herniation could be prevented by widely exposing the cortex, and this allowed the study of laser-tissue interactions in surviving animals, including observation of sharply demarcated, wedge-shaped lesions. 13, 29 Furthermore, the reproducibility of the injuries resulting from pulsed lasers, including subdural and subarachnoid hemorrhage and underlying cerebral edema, led Brown et al. 4 to develop a model for studying these pathologies in rats. When lasers were applied at low power in extracranial animal tumor models in 1964, 2 research groups found that pulsed laser energy appeared to have a selective effect, destroying cancer cells, and this result led to hope for similar benefits for oncological treatment elsewhere in the body. 23, 24 Thus the initial findings regarding pulsed-wave lasers applied to the brain suggested that while useful as a research tool, the traumatic results of high-energy pulses and the unpredictable effects of low-energy pulses appeared to limit their utility in clinical neurosurgery.
A major advance in making lasers more applicable to neurosurgery came with the introduction of continuouswave lasers and improved delivery systems. This type of laser energy eliminated the explosive effects of pulsedwave lasers and allowed accurate cutting and vaporization by using focused beams, without the need to handle or retract the tissue. 13 Investigators also began to take advantage of the fundamental properties of different types of lasers. The long wavelength of the CO 2 laser (10.6 µm) was found to have high absorption in tissue and water, with rapid conversion of light energy into heat in a small volume of tissue. 16 This profile makes the CO 2 laser an excellent cutting tool, as it causes minimal thermal damage to adjacent tissue but limits its ability to coagulate large vessels. Extensive experiments on the lesion characteristics produced by CO 2 laser beams were conducted by Stellar et al. 32 and Ascher, 1 who described characteristic zones, including a vaporized crater surrounded by a zone of desiccated tissue and an outer zone of edematous tissue (Fig. 2 ). Stellar and colleagues also investigated the ability of the CO 2 laser to vaporize and resect a brain tumor in a mouse model, and their results inspired future clinical applications. 32 In contrast to the long wavelength of the CO 2 laser, the argon laser, with a wavelength of 488-516 nm, is scattered more widely in tissue, creating a broader zone of heating and tissue effect, but is absorbed by hemoglobin, producing effective coagulation. 9 The ability of argon and CO 2 lasers to be delivered at high power as a continuous wave led to the first experiments with controlled laser energy in 1967, but the large setup hindered initial use because of the difficulty in getting the beam to the target (Fig. 3) . 13 Newer delivery systems, including fiberoptic cables for shorter wavelength lasers and articulated arms with reflecting mirrors for longer wavelengths, addressed this problem. The Nd:YAG laser, with a wavelength of 1060-1340 nm, was subsequently found to scatter widely in tissue, producing slow, deep heating with a wide area of effect, which is very useful for coagulation. 10 Further experiments in the 1980s expanded the use of Nd:YAG lasers for the anastomosis of blood vessels as well as their coagulating and vaporizing abilities, but their wide thermal effects limited use near eloquent structures.
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First Clinical Experience
Inspired by the selective cancer cell destruction reported after exposure to pulsed ruby laser energy, Rosomoff and Carroll 30 were the first, in 1966, to apply this type of laser to malignant gliomas in humans following standard operative exposure. As the pulse energy needed to be low to avoid explosive damage to adjacent structures, no attempt was made to resect tumor tissue with the laser, and only minimal areas of tumor necrosis were induced, with no improvement in patient survival. Encouraged by their results in animal models, Stellar and colleagues 31, 32 were, in 1969, the first to attempt the resection of a human brain tumor, a recurrent glioblastoma multiforme, by using the continuous-wave CO 2 laser (Fig. 4) . Given the location of the tumor in the left frontal area, gross-total resection was not attempted, but the patient recovered well from the operation with initial neurological improvement. This result led the authors to state that the use of the CO 2 laser for "additional otherwise hopeless human brain tumours is now warranted." Note, however, that logistical issues, including much longer operative times and the cumbersome nature of the articulating arms, which were difficult to use and impeded vision, tempered initial optimism, and few clinical advances took place in the 1970s.
Growing Enthusiasm
The ability of the CO 2 laser to both cut and coagulate with a no-touch technique and minimal tissue trauma convinced some neurosurgeons to continue to explore its utility, although its use remained anecdotal until several large studies were reported at the end of the 1970s and early 1980s. Perhaps most supportive of the new technology was the Ascher and Heppner 2 report of 657 cases from 1976 to 1983 that included 546 intracranial tumors, 33 spinal cases, 26 peripheral nerve cases, and 52 other procedures. The authors praised the precise, no-touch cutting of the CO 2 laser, which made it easy to extirpate tough tumors, and suggested that gliosis and painful neuroma formation were reduced when the laser was used. Moreover, they identified indications for the use of the laser: "absolute" (all fibrous tumors of the midline, pineal region, brainstem, and spinal cord), "relative" (if either the surgeon or patient receives benefit from using the laser), "not indicated" (if conventional tools or methods are superior), and "contraindicated" (only "if somebody uses the laser to solve his Ego problems"). Based on their experiences, the authors incorporated a pilot light to indicate to the surgeon the path and focus of the invisible CO 2 laser beam, and developed a microadapter to maintain the laser at a fixed distance when working under the operating microscope (Fig. 5) . In conclusion, they reflected that "after long years of a lonesome walk we have found today that many neurosurgeons throughout the whole world are in our company and using lasers." Another large series by Takizawa, 33 documented the use of the laser in 160 cases between 1969 and 1982, noting that the device allowed resections to be performed within the cavity of the tumor, limiting the amount of manipulation or retraction on adjacent structures. He remained more moderate about the role of the laser and remarked that adjuvant instruments, including the ultrasonic aspirator and bipolar and loop cautery, remained indispensable. He went on to comment that "the CO 2 laser is nothing more than one of the surgical instruments, but it is no doubt a breakthrough in the surgery of brain tumours. Actually we have encountered many cases where extirpation of the tumour would have been impossible without the CO 2 laser." In 1980 Beck 3 described 120 cases in which was used either the CO 2 or Nd:YAG laser, noting the former had a better profile for cutting and reduced retraction in eloquent areas. In 1983 Edwards and coworkers 9 reported the results of 80 neurosurgical procedures using the CO 2 laser, noting that in 77 cases of mixed intra-and extraaxial cranial and spinal tumors, the laser was rated as "very helpful" or "helpful"; in just 2 cases of dorsal root entry zone lesions it was "not helpful," and in one axillary neuroma it was of "questionable benefit." After reporting that experimental lesions in cat brains showed less blood-brain barrier damage when made with the CO 2 laser compared with bipolar cautery, Cozzens and 
Enthusiasm Tempered
The increasing integration of computers and image guidance into the neurosurgical operating room in the middle to late 1980s meant the rise of computer-assisted, stereotactic laser resection of tumors, pioneered by Kelly. 20 Multiple stereotactic imaging modalities could be utilized to plan the trajectory for, and the resection of, a deep-seated tumor, with a laser attached to the microscope and driven by the computer, and the laser's progress tracked by the surgeon via a cursor on the screen. In 267 cases of deep intracranial tumors, Kelly reported 10% morbidity and 1% mortality rates while achieving aggressive gross-total resection of any tumor visible on imaging. One drawback to this method is the need for a relatively wide transparenchymal corridor to the tumor, which leads to significant collateral damage to neural tissue as opposed to other routes of access, and the technique is seldom used at present.
Endoscopic surgery allows minimally invasive approaches to numerous areas of the body, including an expanding number of intracranial locations. In 1970 Goodale et al. 15 were the first to use a CO 2 laser through a rigid endoscope to coagulate bleeding gastric ulcers. In 1973 Nath et al. 25 reported the first use of a flexible fi- beroptic endoscope along with an argon laser. However, the long wavelength of the CO 2 laser results in an excessive loss of power when transmitted through conventional solid fiberoptic cables, thus preventing its use in this manner. Although there have been reports on the use of argon lasers to fenestrate cysts via steerable endoscopes and a technique to use lasers during endoscopy in the ventricles via a ball tip that converts Nd:YAG light energy to thermal energy has been described, the serious risk of damage to adjacent structures by argon or Nd:YAG laser energy has limited their application in endoscopy. 27, 34, 35 There is a wide range of opinions based on experience with laser systems, and it is likely that the ease of use and ability to manipulate the device are factors that determine whether the laser has utility in the neurosurgical operating room. In the most recent (1996) review of lasers in neurosurgery, Devaux and Roux 7 have expressed their strong support for lasers, stating that these devices play a large role in the neurosurgical armamentarium. In sharp contrast, Laws commented on this review, downplayed the importance of the laser, and said, "I cannot think of a single case that I would cancel if the laser were broken and it is hard to remember the last time I used a laser in clinical surgery." 7 Moreover, in reviewing operative techniques in neurosurgery, Rhoton 28 describes lasers as useful for coagulation and debulking of tumors but personally prefers carefully applied bipolar cautery and microdissection for the removal of tumor adjacent to neural or vascular structures. Given the relative paucity of recent literature on lasers in neurosurgery, these tools do not currently seem to play a prominent role in the neurosurgical operating room. Cumbersome ergonomics, especially of the CO 2 laser systems with bulky articulating arms, and the change in focal distance from attaching a microadapter for the laser to the operating microscope also deter their regular use. The large size of laser units (belied by comments from Stellar and Polanyi 32 in 1970, in an era when a computer could occupy an entire floor: "Suffice to say that this laser is compact, readily fitting into the laboratory or operating room") can also be problematic in modern operating rooms where space for equipment and personnel is at a premium. Finally, the perception that lasers can impede efficiency or slow down procedure time can also be seen as a likely barrier to their common use.
Emerging Technology
The development of a flexible, hollow-core fiber lined with an omnidirectional mirror for the delivery of CO 2 laser energy may help to mitigate some of the above-described problems related to ergonomics. 12, 17 Recent laboratory and clinical experience suggests that it offers the low profile required for working under the microscope while bringing CO 2 laser energy directly to the surgical site (Fig. 6) . 6 Other developments, such as combined Nd:YAG and CO 2 lasers, may offer a single tool to take advantage of the hemostatic and cutting abilities of the 2 lasers. In addition, authors of numerous experiments, mostly in the laboratory but also in the clinical setting, continue to explore the functionality of the laser beyond photocoagulation and vaporization, including laser interstitial thermotherapy and photodynamic therapy for tumors, laser tissue welding such as laser-assisted nerve or vascular anastomosis, and laser discectomy. 21 As the evidence of efficacy increases, well-designed trials will be required to determine the appropriate role of laser procedures in neurosurgical practice.
Conclusions
The utility of various lasers as neurosurgical instruments has been explored since shortly after the discovery of lasers. Experience has led to a refinement in the methods for delivering laser energy to the brain, and the enthusiasm for the use of lasers in the neurosurgical operating room has waxed and waned with these developments, from unbridled optimism to apathy. It seems likely that defining specific roles in which the laser offers clear benefit will be the next stage in their history as they secure a place in the neurosurgical armamentarium. The example of laser technology shows us that often there are excellent ideas that appear to have some innate practical neurosurgical worth, yet what seems to be a straightforward application is problematic or relies on advances in other scientific realms-such as material science in the case of lasers-to become a truly successful technology.
